281
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes

, , , , &
Pages 721-728 | Accepted 14 Dec 2009, Published online: 20 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Peter Bramlage, Claudia Zemmrich, Reinhard Ketelhut, Wolf-Peter Wolf, Eva-Maria Fronk & Roland E Schmieder. (2013) Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice. Vascular Health and Risk Management 9, pages 475-483.
Read now
Krzysztof Narkiewicz. (2012) Angiotensin II receptor blocker combinations: From guidelines to clinical practice. Blood Pressure 21:2, pages 73-81.
Read now
Giuliano Tocci & Massimo Volpe. (2011) Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy. Expert Review of Cardiovascular Therapy 9:7, pages 829-840.
Read now
Lars Christian Rump & Lorenz Sellin. (2010) Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide. Expert Opinion on Pharmacotherapy 11:13, pages 2231-2242.
Read now

Articles from other publishers (12)

Vivianne Presta, Ilaria Figliuzzi, Barbara Citoni, Giovanna Gallo, Allegra Battistoni, Giuliano Tocci & Massimo Volpe. (2021) ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients. High Blood Pressure & Cardiovascular Prevention 28:3, pages 255-262.
Crossref
Massimo Volpe, Caterina Santolamazza, Vittoria Mastromarino, Roberta Coluccia, Allegra Battistoni & Giuliano Tocci. (2017) Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control. High Blood Pressure & Cardiovascular Prevention 24:3, pages 243-253.
Crossref
Katherine A. Lyseng-Williamson. (2016) Olmesartan medoxomil: a guide to its use as monotherapy or in fixed-dose combinations with amlodipine and/or hydrochlorothiazide. Drugs & Therapy Perspectives 32:9, pages 369-380.
Crossref
Rajiv Agarwal & Matthew R. Weir. (2013) Blood pressure response with fixed-dose combination therapy. Journal of Hypertension 31:8, pages 1692-1701.
Crossref
Steven G. Chrysant, F. Wilford Germino & Joel M. Neutel. (2012) Olmesartan Medoxomil-Based Antihypertensive Therapy Evaluated by Ambulatory Blood Pressure Monitoring. American Journal of Cardiovascular Drugs 12:6, pages 375-389.
Crossref
Massimo Volpe, Lars Christian Rump, Bettina Ammentorp & Petra Laeis. (2012) Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan/Amlodipine/Hydrochlorothiazide Combination. Clinical Drug Investigation 32:10, pages 649-664.
Crossref
Massimo Volpe, Lars Christian Rump, Bettina Ammentorp & Petra Laeis. (2012) Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan/Amlodipine/Hydrochlorothiazide Combination. Clinical Drug Investigation, pages 1.
Crossref
Dean J. Kereiakes & Joel M. Neutel. (2012) Seated Cuff Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil-Based Treatment Regimen in Patients with Type 2 Diabetes Mellitus. Drugs in R&D 11:3, pages 251-257.
Crossref
Dean J. Kereiakes & Joel M. Neutel. (2012) Seated Cuff Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil-Based Treatment Regimen in Patients with Type 2 Diabetes Mellitus. Drugs in R & D 11:3, pages 251-257.
Crossref
C. Venkata Ram, Richard Sachson, Thomas Littlejohn, Chunlin Qian, Ali Shojaee, Kathy A. Stoakes & Joel M. Neutel. (2011) Management of Hypertension in Patients With Diabetes Using an Amlodipine-, Olmesartan Medoxomil-, and Hydrochlorothiazide-Based Titration Regimen. The American Journal of Cardiology 107:9, pages 1346-1352.
Crossref
Joel M. Neutel & Dean J. Kereiakes. (2010) An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension. American Journal Cardiovascular Drugs 10:5, pages 289-303.
Crossref
Dean J. KereiakesJoel Neutel. (2010) Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring. Therapeutic Advances in Cardiovascular Disease 4:5, pages 285-293.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.